Owkin is building the first universal AI Operating System called K to lay the foundation for Biological Artificial Superintelligence (BASI). This OS integrates a suite of AI agents that decode complex biology, accelerate research, and dramatically increase productivity. Acting as copilots, Owkin K agents will automate drug discovery and diagnostics and power next-gen pharma companies.
Owkin’s OS will be powered by the world’s largest federated multimodal patient data network, a robotized lab, leading AGI technologies, and cutting-edge multimodal foundation models and LLMs.
Salary range: 185K$-220K$
Owkin is seeking a Director, Business Development to join our fast-growing and dynamic team, with the opportunity to grow our business with pharmaceutical companies by generating new leads, managing key accounts, and contributing to the company's go-to-market strategy.
As a Director, Commercial Sales, you will directly manage your book of work with your key clients and be responsible for identifying and closing new business opportunities with an eye on long-term renewable business with said clients. You will be instrumental in creating awareness of Owkin’s differentiated data and state-of-the art technology, using AI and machine learning to enhance and accelerate R&D, Market access and commercial activities.
The role reports directly to the VP, Commercial Diagnostics, and will be a part of the global commercial team. The position will require intimate cross-team collaboration across multiple departments.
Position is based in our NYC or Boston offices or remote East Coast (DC to Boston).
We’re looking for someone with a proven track record in strategic sales and account management within the pharmaceutical, biotech, or diagnostic industry, particularly with experience in high-value, complex sales related to clinical trials and diagnostic technologies.
Please submit your CV in English
#LI-MD1
If you think that you have been a victim of fraud,
Postman
Samsara
IntRec AI Recruitment
Alliant Insurance Services
Shamrock Trading Corporation